Tularemia is a rare but highly infectious disease caused by Francisella tularensis, a bacterium that can evade immune defenses. Symptoms of infection can include fever, swollen lymph nodes, and—in some cases—pneumonia. What makes the pathogen especially concerning is how little it takes to cause infection—fewer than 10 bacterial cells can be enough. Scientists at Arizona State University have taken a key step toward understanding how this bacterium survives inside the human body. For the first time, the team has isolated and studied a set of proteins that play a central role in infection, revealing a potential weakness that could eventually be targeted with new treatments. The study is published in the journal Biochimica et Biophysica Acta (BBA)–Biomembranes.
The proteins sit within the bacterium’s inner membrane and appear to work together, forming small assemblies that help it persist inside host cells. Until now, researchers had been unable to produce and stabilize these proteins in the lab, leaving a critical part of the pathogen’s biology unexplored. By developing a method to extract and analyze them, the team has opened the door to more detailed structural studies and eventually, new ways to disrupt the infection process.
The work builds on earlier studies of individual proteins, but advances the research by capturing a group of proteins that function together as a system—one that is essential for infection but had remained inaccessible.









